Preparation of enantiomerically pure phenylalanine
Br
J = 1.8 Hz, 1H), 6.76–6.80 (m, 2H), 7.06–7.08 (m, 1H),
7.16–7.19 (m, 2H), 7.26–7.36 (m, 5H), 7.46–7.60 (m, 7H),
8.44 (d, J = 8.4 Hz, 1H). 13C-NMR d 18.7, 38.9, 39.6,
62.4, 65.6, 71.3, 121.1, 123.6, 127.0, 127.2, 127.6, 127.7,
128.4, 128.8, 129.0, 129.1, 129.2, 130.0, 130.1, 131.5,
132.7, 133.4, 133.6, 133.7, 136.2, 142.7, 170.7, 174.7,
178.1.
(SC,RN,SC)-11b: Mp 228–229 °C; [a]2D5 ?1417.4
(c 0.01, CHCl3). 1H-NMR d 2.22 (d, J = 6.9 Hz, 3H), 2.76
(d, J = 17.1 Hz, 1H), 2.78 (d, J = 12.0 Hz, 1H),
3.10–3.30 (m, 2H), 3.95 (q, J = 6.6 Hz, 1H), 4.11 (d,
J = 12.0 Hz, 1H), 4.12 (d, J = 17.1 Hz, 1H), 4.20 (t,
J = 6.3 Hz, 1H), 6.57–6.61 (m, 3H), 6.94–7.18 (m, 4H),
7.21–7.38 (m, 13H), 7.49–7.53 (m, 2H), 8.07 (d,
J = 7.8 Hz, 1H), 8.31 (d, J = 7.2 Hz, 2H). 13C-NMR d
20.1, 40.7, 56.3, 65.1, 65.9, 71.5, 120.4, 123.2, 125.6,
127.1, 127.4, 127.8, 128.5, 128.6, 128.7, 128.8, 128.9,
129.0, 129.6, 129.8, 130.4, 131.5, 132.2, 133.3, 134.0,
135.0, 135.1, 135.6, 142.3, 171.3, 178.1, 178.4.
(SC,SN,SC)-12a: Mp 216–218 °C; [a]2D5 ?1550.8 (c 0.01,
CHCl3). 1H-NMR d 1.67 (d, J = 6.9 Hz, 3H), 2.42 (d,
J = 15.9 Hz, 1H), 2.63 (s, 3H), 3.08 (dd, J = 12.0, 5.1 Hz,
1H), 3.19 (dd, J = 14.2, 4.5 Hz, 1H), 3.49 (q, J = 6.9 Hz,
1H), 3.99 (d, J = 15.9 Hz, 1H), 4.25 (t, J = 6.0 Hz, 1H),
6.77–6.88 (m, 3H), 7.08–7.11 (m, 2H), 7.21–7.35 (m, 8H),
7.40–7.43 (m, 4H), 7.51–7.54 (m, 3H), 8.65 (d,
J = 8.7 Hz, 1H).
(SC,RN,RC)-13a: Mp 104–105 °C; [a]2D5 -1634.1
(c 0.01, CHCl3). 1H-NMR d 1.74 (s, 3H), 1.97 (d,
J = 6.9 Hz, 3H), 2.66 (dd, J = 13.2, 5.4 Hz, 1H), 2.91 (d,
J = 16.8 Hz, 1H), 2.99 (dd, J = 13.2, 3.0 Hz, 1H), 3.20
(d, J = 16.8 Hz, 1H), 3.43 (q, J = 6.9 Hz, 1H), 4.24 (t,
J = 2.1 Hz, 1H), 6.76 (d, J = 4.2 Hz, 2H), 7.06 (d,
J = 6.6 Hz, 1H), 7.22–7.31 (m, 6H), 7.42–7.63 (m, 10H),
8.14 (d, J = 8.4 Hz, 1H).
(SC,RN,RC)-13b: Mp 261–264 °C; [a]2D5 -1756.4
(c 0.01, CHCl3). 1H-NMR d 2.14 (d, J = 6.6 Hz, 3H),
2.71 (d, J = 16.2 Hz, 1H), 3.00–3.15 (m, 2H), 3.23
(d, J = 14.4 Hz, 1H), 3.58 (d, J = 16.2 Hz, 1H), 3.69
(d, J = 14.2 Hz, 1H), 6.67–6.72 (m, 2H), 7.00–7.24
(m, 5H), 7.26–7.75 (m, 17H). 13C-NMR d 20.1, 39.0,
60.1, 62.5, 64.6,71.1, 120.7, 124.8, 127.0, 127.2, 127.6,
128.2, 128.4, 128.6, 128.9, 129.0, 129.9, 130.9, 131.5,
131.8, 132.0, 133.0, 133.8, 136.5, 137.0, 142.3, 170.6,
175.7, 177.8.
(SC,SN,RC)-14b: Mp 245–247 °C; [a]2D5 -1880.8
(c 0.01, CHCl3). 1H-NMR d 1.54 (d, J = 6.9 Hz, 3H),
2.60–2.75 (m, 2H), 3.32 (d, J = 17.7 Hz, 1H), 3.58 (d,
J = 11.7 Hz, 1H), 3.83 (t, J = 7.2 Hz, 1H), 4.32–4.38 (m,
1H), 4.33 (d, J = 16.5 Hz, 1H), 4.41 (d, J = 11.7 Hz, 1H),
5.81 (d, J = 7.5 Hz, 1H), 6.39–6.56 (m, 4H), 6.98–7.72
(m, 8H), 7.28–7.64 (m, 8H), 8.13 (d, J = 7.8 Hz, 1H), 8.20
(d, J = 8.7 Hz, 1H), 8.55 (d, J = 6.9 Hz, 2H).
NH2
O
6
O
NH
O
Br
COBr
7
98%
8
Me
Ph
H
Me
Ph
R
Me
Ph
N
N
NH2
Hünig's
base/RI
O
NH
O
O
NH
O
(S)-5
>95%
quant.
9
10
a
b
R = Me ( ), Bn ( )
Scheme 1 Synthesis of ligands 10a,b
General procedure for disassembly of the Ni(II)
complexes, isolation of phenylalanines (S)-15, (R)-16
and recycling of chiral ligands 10a,b
To a solution of MeOH and 3 N HCl at 70 °C was added
complex 11a,b, 13a,b (14.5 mL MeOH/11 mL of 3 N HCl/
1 g of complex 11a,b, 13a,b). The solution was stirred for
30 min (disappearance of red color) and then evaporated
under vacuum. The residue was treated with 50 mL of DI
water and 15 mL CH2Cl2 and then organic and aqueous layers
were separated and evaporated under vacuum. Ligands 10a,b
were recovered with 95–98 % yields by the evaporation of the
organic layer. Following the evaporation of aqueous layer, the
crystalline residue was dissolved in the minimum amount of
DI water and placed on an ion-exchange column using Dowex
50 X 2-100 resin. The column was first washed with DI water
until neutral, followed by 8 % aqueous ammonium hydroxide
(200 mL) to elute acids 15, 16. This solution was evaporated
to afford target (S)- and (R)-phenylalanines in 93–95 % yield.
The Ni(II) was eluted with concentrated HCl after the column
was returned to neutral pH with DI water.
Results and discussion
To develop the most inexpensive chemical method for
preparation of enantiomerically pure amino acids, we deci-
ded to use ultimately inexpensive chiral auxiliary,
1-(phenyl)ethylamine 5 (Juaristi et al. 1998, 1999)
(Scheme 1), readily available in both enantiomeric forms. In
contrast to the design of ligand 4, bearing 2-amino-2-meth-
ylpropanoic acid, we chose the simplest case of glycine
moiety, expecting high yield and uncomplicated synthesis of
the target ligand.
First, o-aminobenzophenone 6 (Scheme 1) was acylated
with 2-bromoacetyl bromide 7 (Soloshonok et al. 2007) to
give product 8 in 98 % yield. Without additional
123